Risk and outcome of subsequent malignancies after radioactive iodine treatment in differentiated thyroid cancer patients

BACKGROUND: We identified differentiated thyroid cancer (DTC) survivors from SEER registries and performed Poisson regression to calculate the relative risks (RRs) of subsequent malignancies (SMs) by different sites associated with radioactive iodine (RAI) treatment, and the attributable risk propor...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Xiaoran, Yao, Xiaoqin, Feng, Fang, Cheng, Weiwei, Wang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117631/
https://www.ncbi.nlm.nih.gov/pubmed/33980182
http://dx.doi.org/10.1186/s12885-021-08292-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117631/
https://www.ncbi.nlm.nih.gov/pubmed/33980182
http://dx.doi.org/10.1186/s12885-021-08292-8

Ejemplares similares